1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MINK THERAPEUTICS INC
MiNK Therapeutics Inc XNAS: INKT

MiNK Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The co...

Read More
13.51 3.06 (29.28%)
82.22% Fall from 52W High
15.7M
XNAS Volume
High volume+gain today

XNAS 10 Mar, 2026 4:18 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for MiNK Therapeutics Inc is on 18 Mar 2026 for the purpose of MiNK Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
0.0 / 100
Momentum Score
Technically Bearish
25.0 / 100
Analyst Price Target
No estimates available

20

S

9

W

1

O

0

T

SWOT Analysis

MiNK Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..